Dova Pharmaceuticals

























This is news to me. I thought us hematology was supposed to be the growth driver.

Vonjo has been an over-priced dog from day 1 and even more competitors are on the way in this tiny market. Doptelet is going generic soon. It's just a matter of time for the hematology group. Maybe a chance with Rheum now but not worth the risk
 












Vonjo has been an over-priced dog from day 1 and even more competitors are on the way in this tiny market. Doptelet is going generic soon. It's just a matter of time for the hematology group. Maybe a chance with Rheum now but not worth the risk

Tell us you're a primary care rep without telling us....Lol. Vonjo is competitively priced. In fact, one could easily make the case that it should have been priced higher due to the rare patient population. The drug beat expectations in year one and was on pace to triple revenue in year two. Doesn't sound like a dog to me.
 






Tell us you're a primary care rep without telling us....Lol. Vonjo is competitively priced. In fact, one could easily make the case that it should have been priced higher due to the rare patient population. The drug beat expectations in year one and was on pace to triple revenue in year two. Doesn't sound like a dog to me.
You’re all primary care reps. You aren’t special because you order coffee for someone who spent more time in residency.
 


















Who got fired?
PATRICK DOHERTY, a/k/a Regional Business Manager at DOPI/SOPI/MOPEY in FLORIDA. Hired by You Know Who? STAN THE MAN!! There's an EEOC INVESTIGATION STILL!!
Whatever is next for the hematology division at SOBI now that it's for Sale? CHECK Seeking Alpha
  1. But MORE IMPORTANTLY, PAT D GOT NAILED FOR INSIDER TRADING AT CYTOKINETICS. CHECK THE STOCK, DOWN MORE THAN 20 POINTS Wonder What HE DID AT SOBI!!!
DOVA THEN SOBI HIRES ARE THE BOTTOM OF SCUM. YOU MAY HAVE TO GO TO JAIL FOR THEM!!!! THEY ARE NOT WORTH IT. IF YOU WORK THERE, GET OUT!!! NO GOOD NEWS IS COMING.
 






PATRICK DOHERTY, a/k/a Regional Business Manager at DOPI/SOPI/MOPEY in FLORIDA. Hired by You Know Who? STAN THE MAN!! There's an EEOC INVESTIGATION STILL!!
Whatever is next for the hematology division at SOBI now that it's for Sale? CHECK Seeking Alpha
  1. But MORE IMPORTANTLY, PAT D GOT NAILED FOR INSIDER TRADING AT CYTOKINETICS. CHECK THE STOCK, DOWN MORE THAN 20 POINTS Wonder What HE DID AT SOBI!!!
DOVA THEN SOBI HIRES ARE THE BOTTOM OF SCUM. YOU MAY HAVE TO GO TO JAIL FOR THEM!!!! THEY ARE NOT WORTH IT. IF YOU WORK THERE, GET OUT!!! NO GOOD NEWS IS COMING.
 












PATRICK DOHERTY, a/k/a Regional Business Manager at DOPI/SOPI/MOPEY in FLORIDA. Hired by You Know Who? STAN THE MAN!! There's an EEOC INVESTIGATION STILL!!
Whatever is next for the hematology division at SOBI now that it's for Sale? CHECK Seeking Alpha
  1. But MORE IMPORTANTLY, PAT D GOT NAILED FOR INSIDER TRADING AT CYTOKINETICS. CHECK THE STOCK, DOWN MORE THAN 20 POINTS Wonder What HE DID AT SOBI!!!
DOVA THEN SOBI HIRES ARE THE BOTTOM OF SCUM. YOU MAY HAVE TO GO TO JAIL FOR THEM!!!! THEY ARE NOT WORTH IT. IF YOU WORK THERE, GET OUT!!! NO GOOD NEWS IS COMING.

you sound insane. And neither of those people have worked here for years so who tf cares

MM in vonjo marketing is gone
 
























PATRICK DOHERTY, a/k/a Regional Business Manager at DOPI/SOPI/MOPEY in FLORIDA. Hired by You Know Who? STAN THE MAN!! There's an EEOC INVESTIGATION STILL!!
Whatever is next for the hematology division at SOBI now that it's for Sale? CHECK Seeking Alpha
  1. But MORE IMPORTANTLY, PAT D GOT NAILED FOR INSIDER TRADING AT CYTOKINETICS. CHECK THE STOCK, DOWN MORE THAN 20 POINTS Wonder What HE DID AT SOBI!!!
DOVA THEN SOBI HIRES ARE THE BOTTOM OF SCUM. YOU MAY HAVE TO GO TO JAIL FOR THEM!!!! THEY ARE NOT WORTH IT. IF YOU WORK THERE, GET OUT!!! NO GOOD NEWS IS COMING.
 






Tell us you're a primary care rep without telling us....Lol. Vonjo is competitively priced. In fact, one could easily make the case that it should have been priced higher due to the rare patient population. The drug beat expectations in year one and was on pace to triple revenue in year two. Doesn't sound like a dog to me.

Not the price of the drug you idiot, the insane 1.7B amount they paid for it! Huge mistake that is dragging the company down and the CEO is blaming us for his incompetence. This desperate push for off label use will land people in jail, so if you have any sense get out now like all of the CTI Cams, MSL's and many others already have!